![](/img/cover-not-exists.png)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN CAUSES A GREATER REDUCTION IN SKIN SODIUM CONTENT AND INTERSTITIAL VOLUME THAN LOOP DIURETICS IN HEART FAILURE
Santos-Gallego, Carlos G., Ibanez, Juan Antonio Requena, Antonio, Rodolfo San, Botija, Maria Belen Picatoste, Ishikawa, Kiyotake, Vahl, Torsten, Salvo, Angel Sanz, Fuster, Valentin, Badimon, Juan J.Volume:
75
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(20)31702-2
Date:
March, 2020
File:
PDF, 227 KB
2020